PE20080692A1 - CRYSTALLINE FORMS OF 11ß- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFLUORO-17-HYDROXI-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA - Google Patents

CRYSTALLINE FORMS OF 11ß- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFLUORO-17-HYDROXI-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA

Info

Publication number
PE20080692A1
PE20080692A1 PE2007000683A PE2007000683A PE20080692A1 PE 20080692 A1 PE20080692 A1 PE 20080692A1 PE 2007000683 A PE2007000683 A PE 2007000683A PE 2007000683 A PE2007000683 A PE 2007000683A PE 20080692 A1 PE20080692 A1 PE 20080692A1
Authority
PE
Peru
Prior art keywords
17alfa
pregna
acetylphenyl
pentafluoro
dien
Prior art date
Application number
PE2007000683A
Other languages
Spanish (es)
Inventor
Wolfgang Beckmann
Gabriele Winter
Edda Kraemer
Thomas Ginko
Evelin Amoulong
Arwed Cleve
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06090095A external-priority patent/EP1862468A1/en
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PE20080692A1 publication Critical patent/PE20080692A1/en

Links

Abstract

REFERIDA A UNA FORMA CRISTALINA DE 11ß-(4-ACETILFENIL)-20,20,21,21,21-PENTAFLUORO-17-HIDROXI-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA, BAJO LAS FORMAS POLIMORFICAS I Y II, DONDE EL DIFRACTOGRAMA DE RAYOS X EN POLVO PRESENTA LINEAS CON VALORES d=21,4 Å, 7,7 Å, 5,8 Å Y 5,3 Å Y EL DE LA FORMA POLIMORFICA II PRESENTA LINEAS CON VALORES DE d= 5,1 Å, 7,1 Å Y 5,6 Å. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION DE DICHAS FORMAS CRISTALINASREFERRED TO A CRYSTALLINE FORM OF 11ß- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFLUORO-17-HYDROXY-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA, UNDER THE POLYMORPHIC FORMS I AND II, WHERE THE POWDER X-RAY DIFFRACTOGRAM PRESENTS LINES WITH VALUES d = 21.4 Å, 7.7 Å, 5.8 Å AND 5.3 Å AND THAT OF THE POLYMORPHIC FORM II PRESENTS LINES WITH VALUES OF d = 5.1 Å, 7.1 Å, and 5.6 Å. IT IS ALSO REFERRED TO A PROCEDURE FOR THE PREPARATION OF SUCH CRYSTAL FORMS

PE2007000683A 2006-06-02 2007-06-01 CRYSTALLINE FORMS OF 11ß- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFLUORO-17-HYDROXI-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA PE20080692A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81012706P 2006-06-02 2006-06-02
EP06090095A EP1862468A1 (en) 2006-06-02 2006-06-02 Crystalline 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one

Publications (1)

Publication Number Publication Date
PE20080692A1 true PE20080692A1 (en) 2008-08-08

Family

ID=42110862

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000683A PE20080692A1 (en) 2006-06-02 2007-06-01 CRYSTALLINE FORMS OF 11ß- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFLUORO-17-HYDROXI-19-NOR-17ALFA-PREGNA-4,9-DIEN-3-ONA

Country Status (6)

Country Link
CR (1) CR10477A (en)
HN (1) HN2008001791A (en)
IL (1) IL195650A (en)
MA (1) MA30502B1 (en)
PE (1) PE20080692A1 (en)
TW (1) TW200813082A (en)

Also Published As

Publication number Publication date
CR10477A (en) 2009-02-26
IL195650A0 (en) 2009-09-01
IL195650A (en) 2012-08-30
TW200813082A (en) 2008-03-16
MA30502B1 (en) 2009-06-01
HN2008001791A (en) 2011-05-11

Similar Documents

Publication Publication Date Title
UY30639A1 (en) SUBSTITUTED DERIVATIVES OF 2H-FTALAZIN-1-ONA, ITS CRYSTAL FORMS, PREPARATION PROCESS AND APPLICATIONS
AR065136A1 (en) Polymorphic forms of a HCHC MACROCICLIC INHIBITOR. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
TWI368262B (en) Methods of forming field effect transistors on substrates
IL193395A0 (en) Processes and apparatuses for the production of crystalline organic microparticle compositions by micro-milling and crystallization on micro-seed and their use
EP1876157A4 (en) Semiconductor porcelain composition and process for producing the same
ECSP088597A (en) NOVEDOUS HYDROGEN SULPHATE SALT
PL1928872T3 (en) Novel sulphonylpyrroles as inhibitors of hdac
NO20080784L (en) Histondeacetylaseinhibitorer
TW200624588A (en) Organometallic compounds
IL185110A0 (en) Processes for the production of organometallic compounds
WO2007087416A3 (en) Methods of increasing oral bioavailability of tetracyclines
ZA200708909B (en) Process for the double bond hydroisomerization of butenes
IL187816A0 (en) Substituted phenylphosphates as mutual prodrugs of steroids and ??-agonists for the treatment of pulmonary inflammation and bronchoconstriction
EA200601274A1 (en) NEW CRYSTAL FORM III OF AGOMELATIN, THE METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITIONS THAT HERE CONTAINS
HK1132884A1 (en) Production of edible wafers by extrusion
PL1912640T3 (en) Use of the hdac inhibitor panobinostat for the treatment of myeloma
TN2009000174A1 (en) Crystalline forms of aliskiren hemifumarate
GB0516800D0 (en) Organic compound, semiconductor crystal film and method of producing thereof
SI2132204T1 (en) Crystalline forms of an 8-azabicyclos3.2.1coctane compound
WO2007112457A3 (en) Aprepitant polymorph mixtures
GB0613246D0 (en) Production of shaped filamentary structures
IL184945A0 (en) Crystalline forms of pregabalin
EP2216428A4 (en) PROCESS FOR PRODUCING SINGLE CRYSTAL SiC SUBSTRATE AND SINGLE CRYSTAL SiC SUBSTRATE PRODUCED BY THE PROCESS
WO2010011748A3 (en) Synthetic intermediates and processes
PL2220015T3 (en) Azeotrope-like compositions of 1,1,2,3,3-pentafluoropropene

Legal Events

Date Code Title Description
FC Refusal